| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |